DiaMedica Therapeutics Inc. - DMAC
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | Cooperman Leon G. | 6.6% | 3,450,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Dialectic Life Sciences SPV LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Dialectic LS Manager LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Dialectic Capital Management, LP | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Dialectic Partners, LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | John Fichthorn | 0.3% | 153,983 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | TRILL AB | 16.9% | 8,825,742 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Jan Stahlberg | 16.9% | 8,825,742 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Richard Jacinto II | 9.6% | 4,958,823 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.